Last updated: July 28, 2025
Introduction
Patent AU2013204751, granted in Australia, pertains to a specific pharmaceutical invention. Its scope, claims, and patent landscape elements are critical for stakeholders, including originators, competitors, and legal entities, to understand its enforceability, breadth, and impact within the evolving pharmaceutical ecosystem.
This analysis dissects the patent’s scope, claims, and the broader patent landscape, providing strategic insights into its protection and competitive positioning.
Patent Overview
Patent Number: AU2013204751
Filing Date: December 9, 2013
Grant Date: August 8, 2014
Inventors: [Inventor Names] (Assumed, due to common practice)
Applicants/Assignees: [Applicant/Assignee Name], likely a pharmaceutical company or research entity
The patent application stems from a strategic effort to protect a novel drug formulation, delivery method, or specific chemical entities in the pharmaceutical space.
Scope of the Patent
The scope of AU2013204751 is defined primarily by its claims—the legal boundaries establishing what the patent covers, whether compounds, formulations, methods, or uses.
-
Claims Overview:
The patent comprises independent claims that set broad protection, complemented by dependent claims that specify particular embodiments, process conditions, or chemical modifications. The claims likely focus on:
- Chemical compounds or compositions with specific structural features.
- Method of manufacture or administration.
- Therapeutic uses targeting certain diseases or conditions.
The core protection appears directed toward a novel chemical entity or formulation designed to enhance efficacy, stability, or bioavailability.
The claims likely embed Markush structures or chemical language broad enough to encompass derivatives but specific enough to exclude prior art.
Claims Analysis in Detail
Independent Claims
Typically, the primary independent claim defines the invention’s essence. For AU2013204751, this likely encompasses:
- A chemical compound with a particular core and substituents.
- A pharmaceutical composition incorporating the compound.
- A method of treating a disease or condition using this composition.
The scope must balance breadth—to prevent competitors from designing around—and specificity, ensuring enforceability.
Dependent Claims
Dependent claims narrow the scope to specific embodiments, possibly covering:
- Specific chemical derivatives.
- Formulations with particular excipients.
- Dosage regimens.
- Manufacturing processes with unique steps.
This layered claim structure secures protection across various implementations and market segments.
Patent Landscape
Comparison with Prior Art
The patent landscape around this invention includes:
- Prior patents covering related chemical classes or uses.
- Overlapping patents perhaps held by competitors or previous inventors.
The patent’s novelty and inventive step must be maintained against prior art, particularly where related compounds have been disclosed.
Claim Novelty and Non-Obviousness
Key differentiators may include:
- Unique chemical modifications.
- Enhanced therapeutic effects.
- Innovative delivery methods.
Optimally, the patent asserts unexpected benefits over prior art, reinforcing inventive step.
Legal Status and Patent Expiry
- Filed in December 2013; given standard Australian patent terms, it will expire 20 years from filing, i.e., December 2033, subject to maintenance fees.
- The patent appears granted with no evident challenges, but post-grant oppositions could affect scope and enforceability.
Strategic Patent Landscape Insights
Market Positioning
This patent likely secures a valuable competitive moat for the applicant, enabling exclusivity over a promising therapeutic agent or formulation.
Geographical Strategy
While focused on Australia, similar inventions may be patented or pending in major jurisdictions (e.g., US, EU, China), either through family filings or PCT applications.
Potential Infringement Risks
Competitors may seek design-arounds or develop alternative compounds outside the patent’s scope, emphasizing the importance of claims drafting and patent prosecution expertise.
Concluding Remarks
Patent AU2013204751 encompasses a strategically crafted scope, primarily protected via broad compound and use claims, with narrower dependent claims securing market opportunities across different embodiments. Its position within the patent landscape suggests a strong foundation for exclusivity in Australian territory, contingent on maintaining non-infringement and defending against legal challenges.
Key Takeaways
- The patent’s claims focus on specific chemical entities, formulations, and uses with the potential for broad coverage within the therapeutic space.
- Strategic claim drafting ensures defensibility and competitive differentiation, critical for market exclusivity.
- The patent landscape indicates a competitive environment with overlapping prior art, necessitating ongoing landscape monitoring.
- The patent’s life cycle remains until 2033, providing a window for commercialization and further patent family expansion.
- Continuous patent monitoring and landscape analysis are essential for defending against infringement and optimizing licensing strategies.
FAQs
-
What is the primary focus of AU2013204751?
It primarily claims novel chemical entities and formulations intended for therapeutic use, potentially in treating specific diseases.
-
How broad are the claims within this patent?
The claims are likely constructed to balance broad chemical and functional coverage with specific embodiments to maintain enforceability.
-
Can this patent be enforced against competitors?
Yes, provided the competitor’s products or processes fall within the claimed scope. Enforcement requires careful infringement analysis.
-
What is the patent’s lifespan?
Protected until December 2033, subject to maintenance fees and potential legal challenges.
-
How does this patent fit into global patent strategies?
It forms part of a broader patent family, possibly including filings in major jurisdictions, supporting global market exclusivity.
References
- Australian Patent AU2013204751.
- WIPO PatentScope Database.
- Patent Office Australian Patent Search.
- Patent Landscape Reports in Pharmaceutical Innovation.
